TITLE

Hepatitis C virus infection in patients and family members attending two primary care clinics in Puebla, Mexico

AUTHOR(S)
López-Colombo, Aurelio; Meléndez-Mena, Daniel; Sedeño-Monge, Virginia; Camacho-Hernández, Josó R.; Vázquez-Cruz, Eduardo; Morales-Hernández, Eduardo R.; Sosa-Jurado, Francisca; Márquez-Domínguez, Luis; Santos-López, Gerardo
PUB. DATE
November 2014
SOURCE
Annals of Hepatology: Official Journal of the Mexican Associatio;Nov/Dec2014, Vol. 13 Issue 6, p746
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Approximately 180 million persons (~2.8%) globally are estimated to be infected by hepatitis C virus (HCV). HCV prevalence in Mexico has been estimated to be between 1.2 and 1.4%. The aim of present work was to determine the prevalence of HCV infection in patients and family members attending two primary care clinics in Puebla, Mexico. Material and methods. Patients and their accompanying family members in two clinics were invited to participate in this study between May and September 2010. Results. A total of 10,214 persons were included in the study; 120 (1.17%) persons were anti-HCV reactive. Of the reactive subjects, detection of viral RNA was determined in 114 subjects and 36 were positive (31%). The more frequent risk factors were having a family history of cirrhosis (33.1%) and having a blood transfusion prior to 1995 (29%). After a multiple logistic regression analysis only transfusion prior to 1995 resulted significant to HCV transmission (p = 0.004). The overall detected HCV genotypes were as follows: 1a (29%), 1b (48.5%), 2/2b (12.8%), and 3a (6.5%). Conclusion. The HCV prevalence in this population is in agreement with previous studies in other regions of Mexico.
ACCESSION #
99122568

 

Related Articles

  • Hepatitis C. Alper, Brian S.; Selius, Brian A. // Cortlandt Forum;7/25/2005, Vol. 18 Issue 7, p59 

    Presents an overview of hepatitis C. Number of people infected by hepatitis C; Etiology of hepatitis C virus; Prognosis of patient with hepatitis C virus infection.

  • Increased gut permeability in Crohn's disease: is TNF the link?  // Gut;Dec2004, Vol. 53 Issue 12, p1724 

    No abstract available.

  • ASSOCIATION OF HEPATITIS C VIRUS INFECTION TO NON HODGKIN'S LYMPHOMA: IS THE VOLCANO NEAR TO BURST?: A CASE CONTROL STUDY. SHAIKH, BASHIR AHMED; MUHAMMAD, SHAIKH KHALID; GURBAKHSHANI, KOURO MAL // Medical Channel;Oct2011, Vol. 17 Issue 4, p25 

    Introduction & Objectives: Limited data is available on association of HCV infection and NHL in Pakistan. This was a matter of particular interest. So, this study was conducted to determine the association between HCV infection and NHL. Duration & Design: This 2 year observational, case control...

  • ASK DR ANDREW. Gibson, Donna // Woman's Day (Australia Edition);2/21/2005, Vol. 57 Issue 8, p75 

    Provides information on the hepatitis C virus. Rate of the incidence of hepatitis among those infected by the virus; Ways to improve the chance of minimizing liver damage.

  • Desperately seeking hepatitis C virus. Moreno-Otero, Ricardo; Tarantino, Giovanni; Lakatos, Peter L.; Nakajima, Hisato // World Journal of Gastroenterology;5/14/2008, Vol. 14 Issue 18, p2946 

    Spanish investigators described recently the so-called occult hepatitis C virus (HCV) infection, emphasizing the detection of genomic and antigenomic HCV RNA strands in liver and peripheral blood mononuclear cells. Therefore, the persistence of viral replication in occult HCV infection should be...

  • Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy. M Bokemeyer // Gut;Mar2011, Vol. 60 Issue 3, p370 

    OBJECTIVE: Fatigue, mood disturbances and cognitive dysfunction are frequent in patients infected with hepatitis C virus (HCV) who have mild liver disease. The reason is still unclear. The present study aims to gain more insight into the pathomechanism by combining an extensive...

  • Natural killer cells and hepatitis C: action and reaction. Kuldeep Cheent // Gut;Feb2011, Vol. 60 Issue 2, p268 

    In 1989, hepatitis C virus (HCV) was first identified as the infectious agent responsible for human non-A, non-B hepatitis.1Two decades later, HCV remains a global public health problem with a suboptimal response rate to treatment and the absence of a protective vaccine. Recent work has...

  • Hepatitis C virus test receives FDA licensing.  // Geriatrics;Aug1990, Vol. 45 Issue 8, p23 

    The article reports that the Food and Drug Administration has licensed an ELISA test system that detects the presence of antibody to the hepatitis C virus (HCV). HCV is thought to cause more than 90% of transfusion-associated non-A, non-B hepatitis. Clinical studies indicate an HCV antibody...

  • Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studies. Koike, Kazuhiko // Journal of Gastroenterology;2002 Supplement 13, Vol. 37, p55 

    Over the past decade, genetically engineered mouse models have been used for studies of the mechanisms underlying human diseases. One advantage of these models is that the targeted protein executes its function in normal cells in their natural tissue microenvironments. Transgenic mouse models...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics